ARCHIVES

13/11/2013

Fidia Pharma USA Inc to exhibit at AAOS Annual Meeting 2014

Fidia Pharma USA, Inc. will be exhibiting at the Annual Meeting of the American Academy of…
05/04/2013

Fidia Farmaceutici s.p.a. and BMG Pharma s.r.l. have entered into a partnership to promote and sell IALECT® topical gel in Italy

New addition in the company's dermatological portfolio

Abano Terme (Italy) and Milan (Italy) April 3, 2013 - Fidia Farmaceutici S.p.A. (Abano Terme, Italy)…
12/10/2011

Hyalo GYN® Vaginal Hydrating gel available in the US

Fidia Pharma USA Inc, to distribute the product online

Hyalo GYN® supplements the body's natural hydrating function, and is intended for use as a hydrating…
07/10/2011

Moving Ahead in Osteoarthritis: from Science to Therapy

Organizzato da Fidia con il patrocinio dell'Università degli Studi di Padova

Patrocinato dall'Universita' di Padova e promosso da Fidia farmaceutici, il convegno trattera'…
26/09/2011

Fidia Farmaceutici S.p.A. to Distribute and Promote HYALGAN® (sodium hyaluronate) for Treatment of Osteoarthritis

Commercial rights to Hyalgan transitioned from Sanofi back to Fidia, the brand's owner and manufacturer

Wholly-owned subsidiary, Fidia Pharma USA Inc, engages Interpace BioPharma, LLC. to handle distribution and promotional support

PARSIPPANY, N.J., Sept. 26, 2011 /PRNewswire/ -- Fidia Farmaceutici S.p.A. ("Fidia") announced today…
18/11/2008

Genzyme's European patent on cross-linked gel slurries has been entirely revoked by the EPO board of appeal.

Genzyme's EP patent has been finally revoked in its entirety by the EPO Board of Appeal

Fidia Farmaceutici S.p.A. (Abano Terme, Italy) announces that the opposition they filed against…
17/11/2008

APR Applied Pharma Research and Fidia Farmaceutici Receive IND Approval from FDA for a New NSAID Matrix Patch Product

The U.S. FDA has accepted the IND application for the development of a 140mg Diclofenac Sodium Matrix Patch for the topical treatment of acute pain

Applied Pharma Research sa (APR), and Fidia Farmaceutici SpA (Fidia) today announced that the U.S.…

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- advanced wound care
- dermatology
- neurology
- dermo-aesthetics